Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Advicor, Simcor Withdrawals Show There's A Lot Riding On CV Outcomes Studies

Executive Summary

Surrogate markers for cardiovascular products may be going the way of AbbVie's cholesterol franchise.

Advertisement

Related Content

What To Look Out For At ACC
FDA’s Zetia/Vytorin Rejection Leaves Cholesterol Drug Sponsors In Limbo
New Cholesterol Guidelines Follow Long History Of Failed Outcomes Trials
FDA Makes It Formal, Rescinds SPA For Amarin’s ANCHOR Study

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS057598

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel